The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 20, 2014

Filed:

Sep. 22, 2009
Applicants:

Curtis J. Henrich, Rockville, MD (US);

Moon-ii Kang, Gyeongsangnam-do, KR;

Heidi R. Bokesch, Frederick, MD (US);

Kirk R. Gustafson, Frederick, MD (US);

Nancy H. Colburn, Middletown, MD (US);

Matthew R. Young, Ijamsville, MD (US);

James B. Mcmahon, Frederick, MD (US);

Inventors:

Curtis J. Henrich, Rockville, MD (US);

Moon-II Kang, Gyeongsangnam-do, KR;

Heidi R. Bokesch, Frederick, MD (US);

Kirk R. Gustafson, Frederick, MD (US);

Nancy H. Colburn, Middletown, MD (US);

Matthew R. Young, Ijamsville, MD (US);

James B. McMahon, Frederick, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 33/26 (2006.01); A61K 31/655 (2006.01); C07C 309/66 (2006.01); C07C 317/32 (2006.01); A61K 31/10 (2006.01);
U.S. Cl.
CPC ...
C07C 309/66 (2013.01); C07C 317/32 (2013.01); A61K 31/10 (2013.01);
Abstract

An embodiment of the invention provides a pharmaceutical composition comprising a compound of formula (I) a pharmaceutically acceptable salt, prodrug, hydrate, or solvate thereof. Another embodiment of the invention provides a method of treating or preventing a condition associated with increased expression and/or activity of an NFκB pathway using same compounds. A further embodiment of the invention provides a method of diagnosing a condition in an individual using same compounds.


Find Patent Forward Citations

Loading…